Genes, Erbb-2

1 clinical trials · Condition

Record	Firm	Date
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer (NCT04288089)	Eisai Inc.	2020-04-01

Every clearance here is in the API, with alerts when new ones post.